Atlas Trials

Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer

Clinical trial NCT04117945 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT04117945
Sponsor
Academic and Community Cancer Research United
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
BRAF V600E NegativeKRAS Gene Mutation NegativeLocally Advanced Unresectable Colorectal AdenocarcinomaMetastatic Colorectal AdenocarcinomaNRAS Gene Mutation NegativeStage III Colorectal Cancer AJCC v8Stage IIIA Colorectal Cancer AJCC v8Stage IIIB Colorectal Cancer AJCC v8Stage IIIC Colorectal Cancer AJCC v8Stage IV Colorectal Cancer AJCC v8Stage IVA Colorectal Cancer AJCC v8Stage IVB Colorectal Cancer AJCC v8
Start date
2020-03-03
Primary completion
2023-09-05
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.